After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Biomarin Pharmaceutical Inc. is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Biomarin Pharmaceutical Inc. is $16.95B. A total of 1.44 million shares were traded on the day, compared to an average of 2.49M shares.
In the most recent transaction, Mueller Brian sold 5,000 shares of BMRN for 75.19 per share on May 30 ’24. After the transaction, the EVP, Chief Financial Officer now owns 72,159 company shares. In a previous transaction on May 28 ’24, Davis George Eric sold 40,850 shares at 74.51 per share. BMRN shares that EVP, Chief Legal Officer owns now total 56,157.
Among the insiders who sold shares, BIENAIME JEAN JACQUES disposed of 20,000 shares on May 10 ’24 at a per-share price of $81.14. This resulted in the Director holding 474,994 shares of BMRN after the transaction. In another insider transaction, BIENAIME JEAN JACQUES sold 20,000 shares at $81.62 per share on May 09 ’24. Company shares held by the Director now total 474,994.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, BMRN has a high of $99.56 and a low of $73.68.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BMRN’s latest balance sheet shows that the firm has $1.01B in Cash & Short Term Investments as of fiscal 2021. There were $1.09B in debt and $546.50M in liabilities at the time. Its Book Value Per Share was $27.77, while its Total Shareholder’s Equity was $4.27B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMRN is Buy with a score of 4.44.
